已收录 268921 条政策
 政策提纲
  • 暂无提纲
COMPARISON OF ADRENERGIC AGONISTS FOR THE TREATMENT OF VENTRICULAR-FIBRILLATION AND PULSELESS ELECTRICAL-ACTIVITY
[摘要] The primary role of epinephrine for the treatment of ventricular fibrillation (VF) and pulseless electrical activity (PEA) is to increase blood flow to the myocardium and central nervous system and ultimately improve survival. However, despite the administration of epinephrine, survival following VF or PEA is low. In an attempt to improve outcome from VF and PEA, alternative adrenergic agonists (methoxamine, phenylephrine, norepinephrine) which have different pharmacological properties than epinephrine have been evaluated. In order to determine the role of alternative adrenergic agonists for the treatment of VF and PEA this paper will compare the pharmacological properties and pharmacodynamic effects of these drugs to epinephrine. Specifically, receptor physiology along with the effects of adrenergic agonists on coronary perfusion pressure, survival, myocardial oxygen demand, and cerebral blood flow will be discussed.
[发布日期] 1994-12-01 [发布机构] 
[效力级别]  [学科分类] 
[关键词] RESUSCITATION;EPINEPHRINE;METHOXAMINE;PHENYLEPHRINE;NOREPINEPHRINE;VENTRICULAR FIBRILLATION;PULSELESS ELECTRICAL ACTIVITY [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文